Cleared Traditional

K960097 - CHARTR EP

K960097 is the FDA 510(k) clearance for CHARTR EP by Ics Medical Corp.. It is a Class 2 Neurology device (product code GWJ) cleared through the Traditional 510(k) pathway after a 407-day FDA review.

K960097 · Ics Medical Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1997
Decision
407d
Days
Class 2
Risk

K960097 is an FDA 510(k) clearance for the CHARTR EP. Classified as Stimulator, Auditory, Evoked Response (product code GWJ), Class II - Special Controls.

Submitted by Ics Medical Corp. (Schaumburg, US). The FDA issued a Cleared decision on February 21, 1997 after a review of 407 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1900 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Ics Medical Corp. devices

Submission Details

510(k) Number K960097 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 11, 1996
Decision Date February 21, 1997
Days to Decision 407 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
259d slower than avg
Panel avg: 148d · This submission: 407d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWJ Stimulator, Auditory, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWJ Stimulator, Auditory, Evoked Response

All 17
Devices cleared under the same product code (GWJ) and FDA review panel - the closest regulatory comparables to K960097.
MODIFICATION TO BIO-LOGIC EVOKED POTENTIAL FOR ABAER/ NAVIGATOR PRO.
K994149 · Bio-Logic Systems Corp. · Dec 1999
BIO-LOGIC EVOKED POTENTIAL FOR ABAER I
K992807 · Bio-Logic Systems Corp. · Sep 1999
EXCEL AV STIM 1000
K972157 · Excel Tech. , Ltd. · Jan 1998
EVOPORT 100
K863985 · Jedmed Instrument Co. · Jan 1987
40-HZ AUDITORY EVOKED RESPONSE TEST
K862361 · Cadwell Laboratories, Inc. · Sep 1986
INSERT EARPHONES
K862363 · Cadwell Laboratories, Inc. · Sep 1986